Found 5 matching trials
Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)
PHASE1Safety, pharmacokinetics, pharmacodynamics \[CD11b/CD18 (Mac-1) expression\...
Location
Multiple Locations
Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients
PHASE1Safety, tolerability and pharmacokinetics following single doses...
Location
Multiple Locations
Treatments Being Tested
BIIL 284 BS, low dose, pediatric patientsBIIL 284 BS, medium dose, pediatric patientsBIIL 284 BS, high dose, pediatric patientsBIIL 284 BS, low dose, adult patientsBIIL 284 BS, medium dose, adult patientsBIIL 284 BS, high dose, adult patientsPlacebo Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis
PHASE2To investigate efficacy and safety of 3 doses of BIIL 284 BS in active rheu...
Location
Multiple Locations
Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients
PHASE1Safety, tolerability and pharmacokinetics following repeated doses (15-day ...
Location
Multiple Locations
Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease
PHASE2Study to investigate the effect of 12-week treatment with three doses (5, 2...
Location
Multiple Locations